ClinicalTrials.gg
CompletedNCT05855226OTHERUpdated Jul 9, 2026

Effect of Occupational Therapy at Home E-Rehabilitation (OTHER) for Persons Post-stroke

An interventional study of OTHER-intervention (Occupational Therapy at Home E-Rehabilitation) in Stroke, eHealth and Occupational Therapy, sponsored by Amsterdam University of Applied Sciences. Completed at 9 sites in Netherlands. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-07-09.

Sponsored by Amsterdam University of Applied Sciences · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
116
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 122 studies in Stroke with a site in Netherlands — 23 open to participants now, 31 under way, 5 of them phase 3. Stroke · Netherlands.

Enrollment
66th of 91
116 · median 640
Started
2023
with 11 others
No phase
40 of 122
11 open now
Registered
99th of 122
by date

Among the 122 studies in Stroke with a site in Netherlands, this one is the 66th largest by enrollment of the 91 interventional ones that give a count, is one of 12 that started in 2023, is one of 40 with no phase, and was the 99th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

23 of the 122 studies in Stroke with a site in Netherlands are open now. Recruiting first, the newest first:

18 more — sign in →

All 23 open studies →

A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 122 studies in Stroke with a site in Netherlands, or all of them as a file.
02

Study summary

The goal of this (cost)effectiveness study is to compare care as usual with OTHER-intervention in Cerebro Vascular Accident (CVA) older adults in Geriatric Rehabilitation (GR). The main question[s] it aims to answer are:

  1. What is the effectiveness of OTHER, as compared to occupational therapy as usual (CAU), on improving the self-perceived performance in daily activities of community-dwelling older persons post-stroke over a 24-week period after initiation of OTHER or CAU, as measured longitudinally (at week 4, 13 and 26)?

    Secondary:

  2. What is the effectiveness of OTHER on improving satisfaction with the perceived daily performance of community-dwelling persons post-stroke, 26 weeks after start compared to usual OT? (quantitative approach)
  3. What is the effectiveness of OTHER on improving physical activity of community-dwelling persons post-stroke, 26 weeks after start compared to usual OT? (quantitative approach)
  4. What is the effectiveness of OTHER on improving self-management of community-dwelling persons post-stroke, 26 weeks after start compared to usual OT? (quantitative approach)
  5. How do persons post-stroke and OT's experience and how do they reflect on OTHER in supporting a sense of self-management, safety and improving daily functioning? (qualitative approach).
  6. What factors influenced the intervention delivery and the perceived benefits in the OTHER study (process evaluation)? 1) monitoring treatment fidelity, barriers and facilitators for implementation; 2) gain insight into the impact of OTHER on the GR transition to home; 3) to gain insight into what stroke survivors and OT's think of OTHER. 4) how participants, and professionals experience and thoughts they have on the OTHER-intervention in supporting daily functioning and self-management

    Cost-effectiveness

  7. What is the cost-effectiveness of OTHER on improving self-perceived performance in daily activities and Quality Adjusted Life Years (QALYs) of community-dwelling persons post-stroke, 26 weeks after start compared to usual OT? (quantitative approach)

Participants will get the OTHER-intervention treatment given by de occupational therapist which consists of activity monitoring, coaching and videoconferencing to optimalise the transition from clinical care to home.

Researchers will compare care as usual to see if there is a effect on improving the self-perceived performance in daily activities, self-management and improving physical activity .

03

Conditions studied

  • Stroke
  • eHealth
  • Occupational Therapy

Browse trials for

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • be able to walk a few steps with or without a walking device.
  • 60 years or older
  • an assessment score of at least 16 on the (MoCA)
  • an indication for follow up GR at home

Exclusion criteria

Exclusion Criteria:

  • Who are terminally ill
  • Who have severe aphasia; problems with understanding.
  • Who has been assessed legally incapable by a geriatric doctor
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
116 participants (actual)

Study arms

  • No intervention
    Care as usual

    Care as usual, consist of GR rehabilitation when a patient is back at home.

  • Experimental
    OTHER-intervention

    The OTHER-intervention is part of the OT care. Start during inpatient GR rehabilitation and goes on 12 weeks after discharge when a patient is home or starts after discharge from hospital going home. The OT will coach a patient and use a activity monitoring system. Also videoconferencing will be used.

    Other: OTHER-intervention (Occupational Therapy at Home E-Rehabilitation)

Interventions

  • OtherOTHER-intervention (Occupational Therapy at Home E-Rehabilitation)

    The occupational therapist will use activity monitoring and coaching techniques with videoconference during OTHER.

06

What researchers measure

Primary outcomes

  1. Changes in Canadian Occupational Performance measure (COPM-p) at three time points

    The primary outcome measure is 'perceived daily performance' 4 weeks, 12 weeks and 24 weeks after the start of OTHER compared to baseline functioning, measured with the Canadian Occupational Performance measure. The COPM results in a performance score (COPM-p). The COPM is a person-centred, occupation-focused outcome measure for the detection of change in perceived daily performance over time. The COPM results in a performance score (COPM-p) and a satisfaction score (COPM-s). Through a semi-structured interview, persons will prioritize up to five daily activities that deemed most important and rate each on a 10-point scale regarding perceived performance (COPM-p) (1=not able to do at all and 10 = able to do extremely well. The mean COPM-p will be obtained by summing the ratings and dividing them by the number of prioritized activities.

    Time frame: The investigators assess the changes across three time points (one, three and six months)

Secondary outcomes

  1. Changes in Canadian Occupational Performance measure (COPM-s)

    Persons post-stroke satisfaction in performing daily functioning will be measured with the COPM-s(35). Next to the COPM-p, participants rated the prioritized daily activities on a 10-point scale regarding performance satisfaction (COPM-s) (1= not satisfied at all and 10= extremely satisfied).

    Time frame: baseline, 4 weeks after discharge GR, 12 weeks after discharge GR and 24 weeks after discharge GR

  2. Self-management

    Self-management. The Patient-Reported Outcome Occupational Therapy (PROM-OT) is developed to measure the outcome and quality of OT in the Netherlands from a client perspective.The PROM-OT contains 13 questions regarding the outcome of OT for the person (e.g. I can perform my daily activities, whether or not with help/devices (for example self-care, household, leisure, work) and using scoring with 11 point scale (0= lowest score and 10 = highest score). It focusses on daily activities, being able to self-manage related to daily functioning and satisfaction of OT.

    Time frame: baseline, 4 weeks after discharge GR, 12 weeks after discharge GR and 24 weeks after discharge GR

  3. Patient's quality of life.

    The EuroQol-5D-5L(41) will be used to measure 'health-related quality of life' outcomes (HRQOL).The HRQOL is measured on 5 health dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each health dimension has 5 severity levels ranging between no problems to extreme problems. The EQ- visual analogue scale (VAS) measures the persons' self-rated health on a scale from 0 to 100 (0= worst health and 100 the best health). The participants' EQ-5D-5L health states will be converted into utility values the Dutch tariff.

    Time frame: baseline,4 weeks after discharge GR, 12 weeks after discharge GR and 24 weeks after discharge GR

  4. Capability of older people

    The ICEpop CAPability measure for Older people (ICECAP-O) is a measure of capability in older people for use in economic evaluation. Unlike most profile measures used in economic evaluations, the ICECAP-O focuses on wellbeing defined in a broader sense, rather than health. The measure covers attributes of wellbeing that were found to be important to older people in the United Kingdom. ICECAP-O comprises five attributes (the lay terms are in brackets): Attachment (love and friendship), Security (thinking about the future without concern), Role (doing things that make participants feel valued), Enjoyment (enjoyment and pleasure), Control (independence). Score from 1 till 4 (1 = lowest and 4 = highest score

    Time frame: baseline,4 weeks after discharge GR, 12 weeks after discharge GR and 24 weeks after discharge GR

  5. Activity level

    The wearable activity monitor (PAM) will be applied to measure the amount of active movement in minutes per day.

    Time frame: up to 15 weeks

  6. Mobility functioning

    Time up and go test is a screening tool used to test basic mobility skills of frail elderly patients (60-90 years old) an persons with stroke.

    Time frame: baseline and 24 weeks after discharge GR

  7. Satisfaction with OT

    The Patient-Reported Outcome Measure - Occupational Therapy (PROM-OT) is developed to measure the outcome and quality of OT in the Netherlands from a client perspective. The PROM-OT contains 13 questions regarding the outcome of OT for the person (e.g. I can perform my daily activities, whether or not with help/devices (for example self-care, household, leisure, work) and using scoring with 11 point scale (0= lowest score and 10 = highest score). It focusses on daily activities, being able to self-manage related to daily functioning and satisfaction of OT.

    Time frame: baseline, 4 weeks after discharge GR, 12 weeks after discharge GR and 24 weeks after discharge GR

  8. Societal cost

    Costs will be measured from a societal perspective, meaning that all costs related to the intervention will be measured, irrespective of who pays or benefits from them. Cost will be measured using retrospective cost questionnaires administered after 12 weeks and 24 weeks.

    Time frame: 12 weeks after discharge GR and 24 weeks after discharge GR

Other outcomes

  1. Sociodemographic characteristics

    age, gender, date and time of admission hospital or geriatric clinic, date of discharge, the highest level of education, marital status, and living arrangement (minimal Data Set)

    Time frame: baseline

  2. Chronic conditions

    will be measured by the Functional Comorbidity Index (FCI). The FCI is a sum of 18 self-reported comorbid conditions with a score of 0 to 18. A score of 0 indicating no comorbid illness and a score of 18 indicating the highest number of comorbid illnesses. Comorbidities assessed by the index include arthritis, hypertension, asthma, hearing impairment, visual impairment, gastrointestinal disease, chronic obstructive pulmonary disease/emphysema, osteoporosis, angina, anaemia, congestive heart failure or heart disease, heart attack, neurological disease, stroke/transient ischemic attack, peripheral vascular disease, diabetes mellitus (type I or II), depression, degenerative disc disease and obesity.

    Time frame: baseline and 24 weeks after discharge GR

  3. Cognitive functioning

    To classify the severity of cognitive impairment the Montreal Cognitive Assessment (MoCA) will be used. The MoCA is a 30-point test administered in 10 minutes. The MoCA assesses orientation, short-term memory, visuospatial abilities, attention/concentration, language, and aspects of executive functioning. Data on its psychometric properties are limited, but preliminary results suggest that it has good test-retest reliability (+/- 1 point) and internal consistency (0.83). During the feasibility study the investigators experienced participants with light cognitive impairments and the OTHER-intervention was very useful. De score off 16 is based on de feasibility study and literature. The cutoff point for MoCA is a critical point and debated in literature. MoCA uses the cutoff of 26 is inadequate for the stroke setting. Normality range from 19 till 22 in acute stroke phase.

    Time frame: baseline and 24 weeks after discharge GR

07

Study locations

9 sites
  • Behandelcentrum SZR
    Tiel, Gelderland 4003 CA, Netherlands
  • ZZG Herstelcentrum
    Groesbeek, Gerlderland 6561 LE, Netherlands
  • Cicero Zorggroep
    Brunssum, Limburg 6441 CR, Netherlands
  • Sevagram
    Heerlen, Limburg 6419 PB, Netherlands
  • TanteLouise
    Bergen op Zoom, North Brabant 4613 AK, Netherlands
  • Hogeschool van Amsterdam
    Amsterdam-Zuidoost, North Holland 1105 BD, Netherlands
  • GRZ Plus (2 locations, Omring and Zorgcirkel)
    Hoorn, North Holland 1624 AB, Netherlands
  • Vivium Naardenheem
    Naarden, North Holland 1411 HB, Netherlands
  • AxionContinu
    Utrecht, Utrecht 3526KJ, Netherlands
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2023 to primary completion in Mar 2026, 36 months.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 36 months is above that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 30, 2023
First posted
May 11, 2023
StartActual
Mar 13, 2023
Primary completionActual
Mar 20, 2026
CompletionActual
Mar 20, 2026
Last update
Jul 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05855226
Lead sponsor
Amsterdam University of Applied Sciences
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development, Amsterdam UMC
Responsible party
Sanne Pellegrom (MSc. of Health Science - Principal Investigator, Amsterdam University of Applied Sciences) — Principal investigator
First posted
May 11, 2023
Start date
Mar 13, 2023
Primary completion
Mar 20, 2026
Completion
Mar 20, 2026
Last update
Jul 9, 2026

Study contacts

Margo van Hartingsveldt, Dr.
study director · Amsterdam University of Applied Sciences

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion